Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49. • TMO stock is showing upward bias. Get the inside scoop here.Quarterly sales of $11.12 billion increased 5% year-over-year, beating the analyst consensus estimate of $10.91 billion. Organic revenue growth was 3%.“Looking ahead, we’re in a great position to deliver on our 2025 objectives …” said Marc Casper, chairman, president and CEO of Thermo Fisher Sci ...